馃嚭馃嚫路1d agoResearchTier 1 路 Trial registry
NCT07487389: Zilganersen Expanded Access Program for Individuals With Alexander Disease
Study type: EXPANDED_ACCESS. Phase: .
Publisher
C
ClinicalTrials.gov
USA
This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the publisher's original article.
Read originalAt a glance
- Publisher
- ClinicalTrials.gov
- Region
- USA
- Scope
- Research
- Published
- September 29, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Study type: EXPANDED_ACCESS. Phase: .
Source route
Continue on clinicaltrials.gov
Leave the platform to read the original full article on the publisher site.
Source: ClinicalTrials.gov
Scope: Research
Evidence: Tier 1 路 Trial registry
Related coverage
More related coverage
NIHR School for Public Health Research/5h ago
SPHR trainee Jennie Parnham wins NIHR Impact Award
Universit盲tsklinikum Erlangen/3h ago
Langj盲hriges Engagement geehrt
AHA Newsroom/3h ago
Dallas Go Red for Women builds momentum for 2027 luncheon with Beth Corl as chair
Helsinki University Research/4h ago